JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
JAMP PHARMA CORPORATION
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 300MG 600MG 200MG has been permanently discontinued (last updated November 11, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02519461
Strength
300MG 600MG 200MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
TENOFOVIR DISOPROXIL FUMARATE EFAVIRENZ EMTRICITABINE
Tier
Unrated
Last Updated
2026-11-11
Reason for Shortage
Business reasons
Past Reports for This Drug
JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from JAMP PHARMA CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
225MG · DIN 02420694
250MG · DIN 02529459
50MG · DIN 02423227
5MG · DIN 02429217
10MG · DIN 02429225
2.5MG · DIN 02492199
DIN 02532174
DIN 02532182
500MG · DIN 02523825
2MG · DIN 02553341
100MG · DIN 02509172
25MG · DIN 02509164